US Patent Issued to Abbott Diabetes Care on Feb. 24 for "In vivo enzyme activity sensors and methods" (California Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,007, issued on Feb. 24, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"In vivo enzyme activity sensors and methods" was invented by Mark Eshoo (San Diego), Benjamin Feldman (Berkeley, Calif.), Tianmei Ouyang (Fremont, Calif.) and Lam Tran (Dublin, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An in vivo apparatus for determining activity of an enzyme including a reservoir, a predetermined quantity of a reactant contained with the reservoir, and a working electrode having at least one aperture. The reactant is configured to be released from the reservoir through the at least one aperture of the working electrode. The working el...